{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:03:39Z","timestamp":1760781819967,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T00:00:00Z","timestamp":1452211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["310030_153196\/1","310031_134926"],"award-info":[{"award-number":["310030_153196\/1","310031_134926"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Schweizerische Mobiliar Genossenschaft Jubil\u00e4umsstiftung"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s40291-015-0182-z","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T10:28:28Z","timestamp":1452248908000},"page":"125-133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of Cysteamine on Mutant ASL Proteins with Cysteine for Arginine Substitutions"],"prefix":"10.1007","volume":"20","author":[{"given":"Corinne","family":"Inauen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"R\u00fcfenacht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit V.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk","family":"Blom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Nuoffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"H\u00e4berle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,8]]},"reference":[{"issue":"7020","key":"182_CR1","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/bmj.311.7020.1621","volume":"311","author":"RJ Lilford","year":"1995","unstructured":"Lilford RJ, Thornton JG, Braunholtz D. Clinical trials and rare diseases: a way out of a conundrum. BMJ. 1995;311(7020):1621\u20135.","journal-title":"BMJ."},{"key":"182_CR2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1172-7-48","volume":"7","author":"J H\u00e4berle","year":"2012","unstructured":"H\u00e4berle J, Shahbeck N, Ibrahim K, Schmitt B, Scheer I, O\u2019Gorman R, et al. Glutamine supplementation in a child with inherited GS deficiency improves the clinical status and partially corrects the peripheral and central amino acid imbalance. Orphanet J Rare Dis. 2012;7:48. doi: 10.1186\/1750-1172-7-48 .","journal-title":"Orphanet J Rare Dis."},{"issue":"21\u201322","key":"182_CR3","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.drudis.2013.08.006","volume":"18","author":"J Wood","year":"2013","unstructured":"Wood J, Sames L, Moore A, Ekins S. Multifaceted roles of ultra-rare and rare disease patients\/parents in drug discovery. Drug Discov Today. 2013;18(21\u201322):1043\u201351. doi: 10.1016\/j.drudis.2013.08.006 .","journal-title":"Drug Discov Today."},{"issue":"2","key":"182_CR4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ajmg.1320200226","volume":"20","author":"WA Gahl","year":"1985","unstructured":"Gahl WA, Gregg RE, Hoeg JM, Fisher E. In vivo alteration of a mutant human protein using the free thiol cysteamine. Am J Med Genet. 1985;20(2):409\u201317. doi: 10.1002\/ajmg.1320200226 .","journal-title":"Am J Med Genet."},{"issue":"5","key":"182_CR5","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/S0021-9258(18)34954-8","volume":"257","author":"KH Weisgraber","year":"1982","unstructured":"Weisgraber KH, Innerarity TL, Mahley RW. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem. 1982;257(5):2518\u201321.","journal-title":"J Biol Chem."},{"issue":"5","key":"182_CR6","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1172\/JCI115725","volume":"89","author":"AM Aly","year":"1992","unstructured":"Aly AM, Arai M, Hoyer LW. Cysteamine enhances the procoagulant activity of Factor VIII-East Hartford, a dysfunctional protein due to a light chain thrombin cleavage site mutation (arginine-1689 to cysteine). J Clin Invest. 1992;89(5):1375\u201381. doi: 10.1172\/JCI115725 .","journal-title":"J Clin Invest."},{"issue":"2","key":"182_CR7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0021-9258(18)65696-0","volume":"207","author":"MB Hoagland","year":"1954","unstructured":"Hoagland MB, Novelli GD. Biosynthesis of coenzyme A from phospho-pantetheine and of pantetheine from pantothenate. J Biol Chem. 1954;207(2):767\u201373.","journal-title":"J Biol Chem."},{"issue":"15\u201316","key":"182_CR8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.drudis.2013.02.003","volume":"18","author":"M Besouw","year":"2013","unstructured":"Besouw M, Masereeuw R, van den Heuvel L, Levtchenko E. Cysteamine: an old drug with new potential. Drug Discov Today. 2013;18(15\u201316):785\u201392. doi: 10.1016\/j.drudis.2013.02.003 .","journal-title":"Drug Discov Today."},{"issue":"1","key":"182_CR9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1172\/JCI108448","volume":"58","author":"JG Thoene","year":"1976","unstructured":"Thoene JG, Oshima RG, Crawhall JC, Olson DL, Schneider JA. Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo. J Clin Invest. 1976;58(1):180\u20139. doi: 10.1172\/JCI108448 .","journal-title":"J Clin Invest."},{"issue":"2","key":"182_CR10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMra020552","volume":"347","author":"WA Gahl","year":"2002","unstructured":"Gahl WA, Thoene JG, Schneider JA. Cystinosis. N Engl J Med. 2002;347(2):111\u201321. doi: 10.1056\/NEJMra020552 .","journal-title":"N Engl J Med."},{"issue":"8","key":"182_CR11","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1016\/S0021-9258(18)89141-4","volume":"260","author":"RL Pisoni","year":"1985","unstructured":"Pisoni RL, Thoene JG, Christensen HN. Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts. Role in therapeutic cystine removal? J Biol Chem. 1985;260(8):4791\u20138.","journal-title":"J Biol Chem."},{"issue":"1\u20132","key":"182_CR12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymgme.2013.07.008","volume":"110","author":"ML Summar","year":"2013","unstructured":"Summar ML, Koelker S, Freedenberg D, Le Mons C, H\u00e4berle J, Lee HS, et al. The incidence of urea cycle disorders. Mol Genet Metab. 2013;110(1\u20132):179\u201380. doi: 10.1016\/j.ymgme.2013.07.008 .","journal-title":"Mol Genet Metab."},{"issue":"1","key":"182_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/humu.22469","volume":"35","author":"C Balmer","year":"2014","unstructured":"Balmer C, Pandey AV, R\u00fcfenacht V, Nuoffer JM, Fang P, Wong LJ, et al. Mutations and polymorphisms in the human argininosuccinate lyase (ASL) gene. Hum Mutat. 2014;35(1):27\u201335. doi: 10.1002\/humu.22469 .","journal-title":"Hum Mutat."},{"issue":"5","key":"182_CR14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s10545-014-9807-3","volume":"38","author":"L Hu","year":"2015","unstructured":"Hu L, Pandey AV, Balmer C, Eggimann S, R\u00fcfenacht V, Nuoffer JM, et al. Unstable argininosuccinate lyase in variant forms of the urea cycle disorder argininosuccinic aciduria. J Inherit Metab Dis. 2015;38(5):815\u201327. doi: 10.1007\/s10545-014-9807-3 .","journal-title":"J Inherit Metab Dis."},{"issue":"48","key":"182_CR15","doi-asserted-by":"crossref","first-page":"34599","DOI":"10.1074\/jbc.M113.503128","volume":"288","author":"L Hu","year":"2013","unstructured":"Hu L, Pandey AV, Eggimann S, R\u00fcfenacht V, Moslinger D, Nuoffer JM, et al. Understanding the role of argininosuccinate lyase transcript variants in the clinical and biochemical variability of the urea cycle disorder argininosuccinic aciduria. J Biol Chem. 2013;288(48):34599\u2013611. doi: 10.1074\/jbc.M113.503128 .","journal-title":"J Biol Chem."},{"issue":"1","key":"182_CR16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10545-011-9357-x","volume":"35","author":"K Engel","year":"2012","unstructured":"Engel K, Vuissoz JM, Eggimann S, Groux M, Berning C, Hu L, et al. Bacterial expression of mutant argininosuccinate lyase reveals imperfect correlation of in-vitro enzyme activity with clinical phenotype in argininosuccinic aciduria. J Inherit Metab Dis. 2012;35(1):133\u201340. doi: 10.1007\/s10545-011-9357-x .","journal-title":"J Inherit Metab Dis."},{"issue":"51","key":"182_CR17","doi-asserted-by":"crossref","first-page":"15570","DOI":"10.1021\/bi011525m","volume":"40","author":"LM Sampaleanu","year":"2001","unstructured":"Sampaleanu LM, Vallee F, Thompson GD, Howell PL. Three-dimensional structure of the argininosuccinate lyase frequently complementing allele Q286R. Biochemistry. 2001;40(51):15570\u201380.","journal-title":"Biochemistry."},{"issue":"17","key":"182_CR18","doi-asserted-by":"crossref","first-page":"9063","DOI":"10.1073\/pnas.94.17.9063","volume":"94","author":"MA Turner","year":"1997","unstructured":"Turner MA, Simpson A, McInnes RR, Howell PL. Human argininosuccinate lyase: a structural basis for intragenic complementation. Proc Natl Acad Sci USA. 1997;94(17):9063\u20138.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"4","key":"182_CR19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/prot.20251","volume":"57","author":"E Krieger","year":"2004","unstructured":"Krieger E, Darden T, Nabuurs SB, Finkelstein A, Vriend G. Making optimal use of empirical energy functions: force-field parameterization in crystal space. Proteins. 2004;57(4):678\u201383.","journal-title":"Proteins."},{"key":"182_CR20","doi-asserted-by":"crossref","unstructured":"Vriend G. WHAT IF: a molecular modeling and drug design program. J Mol Graph.\u00a01990;8(1):52\u20136, 29.","DOI":"10.1016\/0263-7855(90)80070-V"},{"issue":"2","key":"182_CR21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u201361. doi: 10.1002\/jcc.21334 .","journal-title":"J Comput Chem."},{"issue":"10","key":"182_CR22","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51(10):2778\u201386. doi: 10.1021\/ci200227u .","journal-title":"J Chem Inf Model."},{"issue":"4\u20135","key":"182_CR23","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00439-002-0793-4","volume":"111","author":"M Linnebank","year":"2002","unstructured":"Linnebank M, Tschiedel E, H\u00e4berle J, Linnebank A, Willenbring H, Kleijer WJ, et al. Argininosuccinate lyase (ASL) deficiency: mutation analysis in 27 patients and a completed structure of the human ASL gene. Hum Genet. 2002;111(4\u20135):350\u20139. doi: 10.1007\/s00439-002-0793-4 .","journal-title":"Hum Genet."},{"issue":"5","key":"182_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1023\/A:1020108002877","volume":"25","author":"WJ Kleijer","year":"2002","unstructured":"Kleijer WJ, Garritsen VH, Linnebank M, Mooyer P, Huijmans JG, Mustonen A, et al. Clinical, enzymatic, and molecular genetic characterization of a biochemical variant type of argininosuccinic aciduria: prenatal and postnatal diagnosis in five unrelated families. J Inherit Metab Dis. 2002;25(5):399\u2013410.","journal-title":"J Inherit Metab Dis."},{"issue":"2","key":"182_CR25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00278187","volume":"78","author":"DN Cooper","year":"1988","unstructured":"Cooper DN, Youssoufian H. The CpG dinucleotide and human genetic disease. Hum Genet. 1988;78(2):151\u20135.","journal-title":"Hum Genet."},{"issue":"1","key":"182_CR26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1086\/513898","volume":"61","author":"D Mancini","year":"1997","unstructured":"Mancini D, Singh S, Ainsworth P, Rodenhiser D. Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1). Am J Hum Genet. 1997;61(1):80\u20137. doi: 10.1086\/513898 .","journal-title":"Am J Hum Genet."},{"issue":"1\u20132","key":"182_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0006-8993(94)91516-4","volume":"633","author":"JR Brawer","year":"1994","unstructured":"Brawer JR, Reichard G, Small L, Schipper HM. The origin and composition of peroxidase-positive granules in cysteamine-treated astrocytes in culture. Brain Res. 1994;633(1\u20132):9\u201320 (pii:0006-8993(94)91516-4).","journal-title":"Brain Res."},{"issue":"50","key":"182_CR28","doi-asserted-by":"crossref","first-page":"E3434","DOI":"10.1073\/pnas.1211198109","volume":"109","author":"A Jezegou","year":"2012","unstructured":"Jezegou A, Llinares E, Anne C, Kieffer-Jaquinod S, O\u2019Regan S, Aupetit J, et al. Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy. Proc Natl Acad Sci USA. 2012;109(50):E3434\u201343. doi: 10.1073\/pnas.1211198109 .","journal-title":"Proc Natl Acad Sci USA."},{"issue":"5","key":"182_CR29","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/ijc.25771","volume":"129","author":"XM Wan","year":"2011","unstructured":"Wan XM, Zheng F, Zhang L, Miao YY, Man N, Wen LP. Autophagy-mediated chemosensitization by cysteamine in cancer cells. Int J Cancer. 2011;129(5):1087\u201395. doi: 10.1002\/ijc.25771 .","journal-title":"Int J Cancer."},{"issue":"6","key":"182_CR30","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1203\/00006450-198806000-00018","volume":"23","author":"LA Smolin","year":"1988","unstructured":"Smolin LA, Clark KF, Thoene JG, Gahl WA, Schneider JA. A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis. Pediatr Res. 1988;23(6):616\u201320. doi: 10.1203\/00006450-198806000-00018 .","journal-title":"Pediatr Res."},{"key":"182_CR31","doi-asserted-by":"crossref","unstructured":"Hua Long L, Halliwell B. Oxidation and generation of hydrogen peroxide by thiol compounds in commonly used cell culture media. Biochem Biophys Res Commun. 2001;286(5):991\u20134. doi: 10.1006\/bbrc.2001.5514 .","DOI":"10.1006\/bbrc.2001.5514"},{"issue":"Suppl 1","key":"182_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1005345205403","volume":"21","author":"M Yudkoff","year":"1998","unstructured":"Yudkoff M, Daikhin Y, Ye X, Wilson JM, Batshaw ML. In vivo measurement of ureagenesis with stable isotopes. J Inherit Metab Dis. 1998;21(Suppl 1):21\u20139.","journal-title":"J Inherit Metab Dis."}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-015-0182-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40291-015-0182-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-015-0182-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T18:03:17Z","timestamp":1718301797000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40291-015-0182-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,8]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["182"],"URL":"https:\/\/doi.org\/10.1007\/s40291-015-0182-z","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"type":"print","value":"1177-1062"},{"type":"electronic","value":"1179-2000"}],"subject":[],"published":{"date-parts":[[2016,1,8]]}}}